kaiser permanente glp-1 coverage policy Medicaid Coverage of and Spending on GLP-1s GLP-1 insurance change impacts millions

Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferation

Key facts: Medicaid launch : as early as May 2026 Participation : voluntary for states states must opt in Pricing : CMS negotiates directly with Eli Lilly (Zepbound/Mounjaro) and Novo Nordisk (Wegovy/Ozempic)

Among the observational studies 39,45,46,49,50,51 comprised by the meta-analyses, two are worth a separate mention

They highlight an ingredient called "Meglutide" along with plant-based compounds such as Moringa extract, peppermint oil, MCT oil, and other herbal ingredients

The bottom line While FDA-approved GLP-1 medications like Ozempic and Wegovy have been extensively studied for managing diabetes and weight loss, the same cant be said about GLP-1 dietary supplements